AA
XBIT icon

ALPS Advisors’s XBiotech XBIT Stock Holding History

ALPS Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35,176
Closed -$392K – 998
2021
Q4 		$392K Sell
35,176
-2,054
-6% -$26.7K ﹤0.01% 687
2021
Q3 		$482K Sell
37,230
-2,256
-6% -$35.9K ﹤0.01% 508
2021
Q2 		$654K Sell
39,486
-13,446
-25% -$228K 0.01% 486
2021
Q1 		$909K Buy
52,932
+534
+1% +$9.97K 0.01% 406
2020
Q4 		$820K Buy
52,398
+15,435
+42% +$284K 0.01% 411
2020
Q3 		$706K Sell
36,963
-2,396
-6% -$41.4K 0.01% 386
2020
Q2 		$540K Sell
39,359
-9,889
-20% -$139K 0.01% 441
2020
Q1 		$523K Sell
49,248
-34,160
-41% -$556K 0.01% 430
2019
Q4 		$1.56M Buy
+83,408
New +$1.07M 0.01% 258
2016
Q2 		– Sell
-36,194
Closed -$342K – 637
2016
Q1 		$342K Sell
36,194
-6,203
-15% -$51.4K ﹤0.01% 574
2015
Q4 		$461K Sell
42,397
-7,665
-15% -$97.9K ﹤0.01% 529
2015
Q3 		$7.48K Buy
50,062
+18,596
+59% +$325K 0.01% 225
2015
Q2 		$569K Buy
+31,466
New +$653K ﹤0.01% 348

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ALPS Advisors's XBIT Position: Q1 2022 in Review

ALPS Advisors sold out of XBiotech (XBIT) in Q1 2022, closing a stake of 35,176 shares — an estimated $392K sold.

ALPS Advisors first reported a position in XBIT in Q2 2015 and held it in 13 quarters. The position peaked at $1.56M in Q4 2019. 64 funds tracked by Wall St. Rank hold XBIT as of Q1 2022.

  • ALPS Advisors reported no remaining XBiotech position as of Q1 2022 after selling out during the quarter.
  • ALPS Advisors sold 35,176 XBiotech shares in Q1 2022, an estimated $392K.
  • ALPS Advisors first reported a position in XBiotech in Q2 2015 and held it in 13 quarters.
  • ALPS Advisors's XBiotech position peaked at $1.56M in Q4 2019.
  • 64 funds tracked by Wall St. Rank held XBiotech as of Q1 2022.

Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.